Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 52

1.

Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.

Liau LM, Ashkan K, Tran DD, Campian JL, Trusheim JE, Cobbs CS, Heth JA, Salacz M, Taylor S, D'Andre SD, Iwamoto FM, Dropcho EJ, Moshel YA, Walter KA, Pillainayagam CP, Aiken R, Chaudhary R, Goldlust SA, Bota DA, Duic P, Grewal J, Elinzano H, Toms SA, Lillehei KO, Mikkelsen T, Walbert T, Abram SR, Brenner AJ, Brem S, Ewend MG, Khagi S, Portnow J, Kim LJ, Loudon WG, Thompson RC, Avigan DE, Fink KL, Geoffroy FJ, Lindhorst S, Lutzky J, Sloan AE, Schackert G, Krex D, Meisel HJ, Wu J, Davis RP, Duma C, Etame AB, Mathieu D, Kesari S, Piccioni D, Westphal M, Baskin DS, New PZ, Lacroix M, May SA, Pluard TJ, Tse V, Green RM, Villano JL, Pearlman M, Petrecca K, Schulder M, Taylor LP, Maida AE, Prins RM, Cloughesy TF, Mulholland P, Bosch ML.

J Transl Med. 2018 Jun 29;16(1):179. doi: 10.1186/s12967-018-1552-1.

2.

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.

Liau LM, Ashkan K, Tran DD, Campian JL, Trusheim JE, Cobbs CS, Heth JA, Salacz M, Taylor S, D'Andre SD, Iwamoto FM, Dropcho EJ, Moshel YA, Walter KA, Pillainayagam CP, Aiken R, Chaudhary R, Goldlust SA, Bota DA, Duic P, Grewal J, Elinzano H, Toms SA, Lillehei KO, Mikkelsen T, Walbert T, Abram SR, Brenner AJ, Brem S, Ewend MG, Khagi S, Portnow J, Kim LJ, Loudon WG, Thompson RC, Avigan DE, Fink KL, Geoffroy FJ, Lindhorst S, Lutzky J, Sloan AE, Schackert G, Krex D, Meisel HJ, Wu J, Davis RP, Duma C, Etame AB, Mathieu D, Kesari S, Piccioni D, Westphal M, Baskin DS, New PZ, Lacroix M, May SA, Pluard TJ, Tse V, Green RM, Villano JL, Pearlman M, Petrecca K, Schulder M, Taylor LP, Maida AE, Prins RM, Cloughesy TF, Mulholland P, Bosch ML.

J Transl Med. 2018 May 29;16(1):142. doi: 10.1186/s12967-018-1507-6. Erratum in: J Transl Med. 2018 Jun 29;16(1):179.

3.

Disseminated choroid plexus papillomas in adults: A case series and review of the literature.

Abdulkader MM, Mansour NH, Van Gompel JJ, Bosh GA, Dropcho EJ, Bonnin JM, Cohen-Gadol AA.

J Clin Neurosci. 2016 Oct;32:148-54. doi: 10.1016/j.jocn.2016.04.002. Epub 2016 Jun 29.

PMID:
27372242
4.

Proton therapy for atypical meningiomas.

McDonald MW, Plankenhorn DA, McMullen KP, Henderson MA, Dropcho EJ, Shah MV, Cohen-Gadol AA.

J Neurooncol. 2015 May;123(1):123-8. doi: 10.1007/s11060-015-1770-9. Epub 2015 Apr 10.

5.

Neurologic complications of lung cancer.

Dropcho EJ.

Handb Clin Neurol. 2014;119:335-61. doi: 10.1016/B978-0-7020-4086-3.00022-9. Review.

PMID:
24365305
6.

Should the cost of care for patients with glioblastoma influence treatment decisions?

Dropcho EJ.

Continuum (Minneap Minn). 2012 Apr;18(2):416-20. doi: 10.1212/01.CON.0000413667.65668.ae.

PMID:
22810136
7.

The neurologic side effects of chemotherapeutic agents.

Dropcho EJ.

Continuum (Minneap Minn). 2011 Feb;17(1 Neurologic Complications of Systemic Disease):95-112. doi: 10.1212/01.CON.0000394676.67372.87.

PMID:
22810790
8.

Neurotoxicity of cancer chemotherapy.

Dropcho EJ.

Semin Neurol. 2010 Jul;30(3):273-86. doi: 10.1055/s-0030-1255217. Epub 2010 Jun 24. Review.

PMID:
20577934
9.

Neurotoxicity of radiation therapy.

Dropcho EJ.

Neurol Clin. 2010 Feb;28(1):217-34. doi: 10.1016/j.ncl.2009.09.008. Review.

PMID:
19932383
10.

Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme.

Reardon DA, Fink KL, Mikkelsen T, Cloughesy TF, O'Neill A, Plotkin S, Glantz M, Ravin P, Raizer JJ, Rich KM, Schiff D, Shapiro WR, Burdette-Radoux S, Dropcho EJ, Wittemer SM, Nippgen J, Picard M, Nabors LB.

J Clin Oncol. 2008 Dec 1;26(34):5610-7. doi: 10.1200/JCO.2008.16.7510. Epub 2008 Nov 3.

PMID:
18981465
11.

Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis.

Mathew RM, Vandenberghe R, Garcia-Merino A, Yamamoto T, Landolfi JC, Rosenfeld MR, Rossi JE, Thiessen B, Dropcho EJ, Dalmau J.

Neurology. 2007 Mar 20;68(12):900-5. Epub 2006 Dec 6.

12.

Immunotherapy for paraneoplastic neurological disorders.

Dropcho EJ.

Expert Opin Biol Ther. 2005 Oct;5(10):1339-48. Review.

PMID:
16197339
13.

Update on paraneoplastic syndromes.

Dropcho EJ.

Curr Opin Neurol. 2005 Jun;18(3):331-6. Review.

PMID:
15891421
14.

Neurotoxicity of cancer chemotherapy.

Dropcho EJ.

Semin Neurol. 2004 Dec;24(4):419-26. Review.

PMID:
15637653
15.

Anti-Hu antibody neuropathy: a clinical, electrophysiological, and pathological study.

Oh SJ, G├╝rtekin Y, Dropcho EJ, King P, Claussen GC.

Clin Neurophysiol. 2005 Jan;116(1):28-34.

PMID:
15589180
16.

Low-Grade Gliomas in Adults.

Dropcho EJ.

Curr Treat Options Neurol. 2004 Jul;6(4):265-271.

PMID:
15157404
17.

Antiphospholipid and glutamic acid decarboxylase antibodies in patients with focal epilepsy.

Sokol DK, McIntyre JA, Wagenknecht DR, Dropcho EJ, Patel H, Salanova V, da Costa G.

Neurology. 2004 Feb 10;62(3):517-8. No abstract available.

PMID:
14872052
18.

Neurologic paraneoplastic syndromes.

Dropcho EJ.

Curr Oncol Rep. 2004 Jan;6(1):26-31. Review.

PMID:
14664757
19.

Novel chemotherapeutic approaches to brain tumors.

Dropcho EJ.

Hematol Oncol Clin North Am. 2001 Dec;15(6):1027-52. Review.

PMID:
11770297
20.

Remote neurologic manifestations of cancer.

Dropcho EJ.

Neurol Clin. 2002 Feb;20(1):85-122, vi. Review.

PMID:
11754303

Supplemental Content

Loading ...
Support Center